Consensus statement on the diagnosis and treatment of children with idiopathic short stature: A summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 11, 2008, Pages 4210-4217

  Cohen, Pinchas ^a   Rogol, A D ^b   Deal, C L ^c   Saenger, P ^d   Reiter, E O ^e   Ross, J L ^f   Chernausek, S D ^g   Savage, M O ^h   Wit, J M ⁱ  

^a MATTEL CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF MONTREAL   (Canada)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f THOMAS JEFFERSON UNIVERSITY   (United States)

^g UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^h QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

ⁱ LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN; GROWTH HORMONE; OXANDROLONE; TESTOSTERONE;

CONFERENCE PAPER; COST BENEFIT ANALYSIS; DECISION MAKING; DIAGNOSTIC TEST; EVIDENCE BASED PRACTICE; GENETIC ANALYSIS; HORMONAL THERAPY; HUMAN; METABOLIC DISORDER; PREVALENCE; PRIORITY JOURNAL; PSYCHOTHERAPY; PUBERTY; SHORT STATURE; TREATMENT OUTCOME;

EID: 57449113415     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-0509     Document Type: Conference Paper

References (39)

1. 1998 Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. J Clin Endocrinol Metab 83:379-381
2. 2000 Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. J Clin Endocrinol Metab 85:3990-3993
3. Ho KK, 2007 GH Deficiency Consensus Workshop Participants 2007 Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency. II. A summary statement of the Growth Hormone Research Society in association with the European Society for Pediatric Endocrinology, the Lawson Wilkins Society, the European Society for Endocrinology, the Japan Endocrine Society and the Endocrine Society of Australia. Eur J Endocrinol 157:695-700
4. Wit JM, Clayton PE, Rogol AD, Savage MO, Saenger PH, Cohen P 2008 Idiopathic short stature: definition, epidemiology, and diagnostic evaluation. Growth Horm IGF Res 18:89-110
5. Wit JM, Reiter EO, Ross JL, Saenger PH, Savage MO, Rogol AD, Cohen P 2008 Idiopathic short stature: management and growth hormone treatment. Growth Horm IGF Res 18:111-135
6. Ranke MB 1996 Towards a consensus on the definition of idiopathic short stature. Horm Res 45(Suppl 2):64-66
7. Lindsay R, Feldkamp M, Harris D, Robertson J, Rallison M 1994 Utah Growth Study: growth standards and the prevalence of growth hormone deficiency. J Pediatr 125:29-35
8. Hermanussen M, Cole J 2003 The calculation of target height reconsidered. Horm Res 59:180-183
9. Luo ZC, Albertsson-Wikland K, Karlberg J 1998 Target height as predicted by parental heights in a population-based study. Pediatr Res 44:563-571
10. Centers for Disease Control 2000 CDC growth charts: United States. http://www.cdc.gov/growthcharts/
11. World Health Organization 2008 The WHO child growth standards. http://www.who.int/childgrowth/en/
12. Cianfarani S, Liguori A, Boemi S, Maghnie M, Iughetti L, Wasniewska M, Street ME, Zucchini S, Aimaretti G, Germani D 2005 Inaccuracy of insulin-like growth factor (IGF) binding protein (IGFBP)-3 assessment in the diagnosis of growth hormone (GH) deficiency from childhood to young adulthood: association to low GH dependency of IGF-II and presence of circulating IGFBP-3 18-kilodalton fragment. J Clin Endocrinol Metab 90:6028-6034
13. Rappold G, Blum WF, Shavrikova EP, Crowe BJ, Roeth R, Quigley CA, Ross JL, Niesler B 2007 Genotypes and phenotypes in children with short stature: clinical indicators of SHOX haploinsufficiency. J Med Genet 44:306-313
14. Visser-van Balen H, Geenen R, Kamp GA, Huisman J, Wit JM, Sinnema G 2007 Long-term psychosocial consequences of hormone treatment for short stature. Acta Paediatr 96:715-719
15. Sandberg DE, Colsman M 2005 Growth hormone treatment of short stature: status of the quality of life rationale. Horm Res 63:275-283
16. Allen DB, Fost NC 2004 Growth hormone for short stature: ethical issues raised by expanded access. J Pediatr 144:648-652
17. Ross JL, Sandberg DE, Rose SR, Leschek EW, Baron J, Chipman JJ, Cassorla FG, Quigley CA, Crowe BJ, Roberts K, Cutler Jr GB 2004 Psychological adaptation in children with idiopathic short stature treated with growth hormone or placebo. J Clin Endocrinol Metab 89:4873-4878
18. De Luca F, Argente J, Cavallo L, Crowne E, Delemarre-Van de Waal HA, De Sanctis C, Di Maio S, Norjavaara E, Oostdijk W, Severi F, Tonini G, Trifiro G, Voorhoeve PG, Wu F 2001 International Workshop on Management of Puberty for Optimum Auxological Results. Management of puberty in constitutional delay of growth and puberty. J Pediatr Endocrinol Metab 14(Suppl 2):953-957
19. Chernausek SD, Backeljauw PF, Frane J, Kuntze J, Underwood LE, GH Insensitivity Syndrome Collaborative Group 2007 Long-term treatment with recombinant insulin-like growth factor (IGF)-I in children with severe IGF-I deficiency due to growth hormone insensitivity. J Clin Endocrinol Metab 92:902-910
20. Yanovski JA, Rose SR, Municchi G, Pescovitz OH, Hill SC, Cassorla FG, Cutler Jr GB 2003 Treatment with a luteinizing hormone-releasing hormone agonist in adolescents with short stature. N Engl J Med 348:908-917
21. Mazur T, Clopper RR 1991 Pubertal disorders: psychology and clinical management. Endocrinol Metab Clin North Am 20:211-227
22. Hero M, Wickman S, Dunkel L 2006 Treatment with the aromatase inhibitor letrozole during adolescence increases near-final height in boys with constitutional delay of puberty. Clin Endocrinol (Oxf) 64:510-513
23. Mauras N, Gonzalez de Pijem L, Hsiang HY, Desrosiers P, Rapaport, R, Schwartz ID, Klein KO, Singh RJ, Miyamoto A, Bishop K 2008 Anastrozole increases predicted adult height of short adolescent males treated with growth hormone: a randomized, double-blind, placebo-controlled multicenter trial for one to three years. J Clin Endocrinol Metab 93:823-831
24. Wit JM, Rekers-Mombarg LT 2002 Dutch Growth Hormone Advisory Group. Final height gain by GH therapy in children with idiopathic short stature is dose dependent. J Clin Endocrinol Metab 87:604-611
25. Ranke MB, Lindberg A, Price DA, Darendeliler F, Albertsson-Wikland K, Wilton P, Reiter EO 2007 KIGS International Board. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature. Horm Res 68:53-62
26. Bryant J, Baxter L, Cave CB, Milne R 2007 Recombinant growth hormone for idiopathic short stature in children and adolescents. Cochrane Database Syst Rev Jul 18:CD004440
27. Hintz RL, Attie KM, Baptista J, Roche A 1999 Effect of growth hormone treatment on adult height of children with idiopathic short stature. Genentech Collaborative Group. N Engl J Med 340:502-507
28. Wit JM, Rekers-Mombarg LT, Cutler GB, Crowe B, Beck TJ, Roberts K, Gill A, Chaussain JL, Frisch H, Yturriaga R, Attanasio AF 2005 Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effect. J Pediatr 146:45-53
29. Finkelstein BS, Imperiale TF, Speroff T, Marrero U, Radcliffe DJ, Cuttler L 2002 Effect of growth hormone therapy on height in children with idiopathic short stature: a meta-analysis. Arch Pediatr Adolesc Med 156:230-240
30. Leschek EW, Rose SR, Yanovski JA, Troendle JF, Quigley CA, Chipman JJ, Crowe BJ, Ross JL, Cassorla FG, Blum WF, Cutler Jr GB, Baron J, National Institute of Child Health and Human Development-Eli Lilly, Co. Growth Hormone Collaborative Group 2004 Effect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 89:3140-3148
31. Kamp GA, Waelkens JJ, de Muinck Keizer-Schrama SM, Delemarre-Van de Waal HA, Verhoeven-Wind L, Zwinderman AH, Wit JM 2002 High dose growth hormone treatment induces acceleration of skeletal maturation and an earlier onset of puberty in children with idiopathic short stature. Arch Dis Child 87:215-220
32. Cohen P, Rogol AD, Howard CP, Bright GM, Kappelgaard AM, Rosenfeld RG, American Norditropin Study Group 2007 Insulin growth factor-based dosing of growth hormone therapy in children: a randomized, controlled study. J Clin Endocrinol Metab 92:2480-2486
33. Clayton PE, Cianfarani S, Czernichow P, Johannsson G, Rapaport R, Rogol A 2007 Management of the child born small for gestational age through to adulthood: a consensus statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society. J Clin Endocrinol Metab 92:804-810
34. US Food and Drug Administration www.fda.gov/medwatch/SAFETY/2003/ 03Jul_PI/Humatrope_PI.pdf
35. Tanaka T 2007 Sufficiently long-term treatment with combined growth hormone and gonadotropin-releasing hormone analogue can improve adult height in short children with isolated growth hormone deficiency (GHD) and non-GHD short children. Pediatr Endocr Rev 5:471-481
36. van Gool SA, Kamp GA, Visser-van Balen H, Mul D, Waelkens JJ, Jansen M, Verhoeven-Wind L, Delemarre-van de Waal HA, de Muinck Keizer-Schrama SM, Leusink G, Roos JC, Wit JM 2007 Final height outcome after three years of growth hormone and gonadotropin-releasing hormone agonist treatment in short adolescents with relatively early puberty. J Clin Endocrinol Metab 92:1402-1408
37. Tanaka T, Cohen P, E Clayton P, Laron Z, L Hintz R, C Sizonenko P 2002 Diagnosis and management of growth hormone deficiency in childhood and adolescence. Part 2. Growth hormone treatment in growth hormone deficient children. Growth Horm IGF Res 12:323-341
38. Quigley CA, Gill AM, Crowe BJ, Robling K, Chipman JJ, Rose SR, Ross JL, Cassorla FG, Wolka AM, Wit JM, Rekers-Mombarg LT, Cutler Jr GB 2005 Safety of growth hormone treatment in pediatric patients with idiopathic short stature. J Clin Endocrinol Metab 90:5188-5196
39. Bakker B, Frane J, Anhalt H, Lippe B, Rosenfeld RG 2008 Height velocity targets from the national cooperative growth study for first-year growth hormone responses in short children. J Clin Endocrinol Metab 93:352-357